Disc Medicine

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31 2023-12-31 2023-09-30
Revenue
$0
$0
$0
$0
Gross Profit
-110
-26
-25
-25
EBITDA
-30,742
-31,436
-29,689
-18,933
EBIT
-30,852
-31,462
-29,714
-18,958
Net Income
-26,352
-26,949
-23,579
-14,122
Net Change In Cash
0
0
0
0
Free Cash Flow
-15,392
-33,666
-17,799
-7,521
Cash
500,945
342,615
360,382
370,541
Basic Shares
25,649
24,809
23,562
24,316

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$0
$0
$0
$0
Gross Profit
-100
-300
-192
-322
EBITDA
-91,025
-47,386
-25,851
-33,681
EBIT
-91,125
-47,475
-26,043
-34,003
Net Income
-76,429
-46,090
-41,005
-47,663
Net Change In Cash
0
0
0
0
Free Cash Flow
-73,551
-42,403
-27,602
-32,730
Cash
360,382
194,611
88,036
1,212
Basic Shares
22,315
1,039
3,202
4,530

Earnings Calls

Quarter EPS
2024-06-30
-$1.03
2024-03-31
-$1.09
2023-12-31
-$0.90
2023-09-30
-$0.58